Publications by authors named "Naveena Singh"

91Publications

Lectins in Cervical Screening.

Cancers (Basel) 2020 Jul 16;12(7). Epub 2020 Jul 16.

Wolfson Institute of Preventive Medicine, Centre for Cancer Prevention, Barts & The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers12071928DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409129PMC
July 2020

Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium.

Authors:
Filipe Correia Martins Dominique-Laurent Couturier Anna Paterson Anthony N Karnezis Christine Chow Tayyebeh M Nazeran Adekunle Odunsi Aleksandra Gentry-Maharaj Aleksandra Vrvilo Alexander Hein Aline Talhouk Ana Osorio Andreas D Hartkopf Angela Brooks-Wilson Anna DeFazio Anna Fischer Arndt Hartmann Brenda Y Hernandez Bryan M McCauley Chloe Karpinskyj Christiani B de Sousa Claus Høgdall Daniel G Tiezzi Esther Herpel Florin Andrei Taran Francesmary Modugno Gary Keeney Gregg Nelson Helen Steed Honglin Song Hugh Luk Javier Benitez Jennifer Alsop Jennifer M Koziak Jenny Lester Joseph H Rothstein Jurandyr M de Andrade Lene Lundvall Luis Paz-Ares Luis Robles-Díaz Lynne R Wilkens Maria J Garcia Maria P Intermaggio Marie-Lyne Alcaraz Mary A Brett Matthias W Beckmann Mercedes Jimenez-Linan Michael Anglesio Michael E Carney Michael Schneider Nadia Traficante Nadja Pejovic Naveena Singh Nhu Le Peter Sinn Prafull Ghatage Ramona Erber Robert Edwards Robert Vierkant Roberta B Ness Samuel Leung Sandra Orsulic Sara Y Brucker Scott H Kaufmann Sian Fereday Simon Gayther Stacey J Winham Stefan Kommoss Tanja Pejovic Teri A Longacre Valerie McGuire Valerie Rhenius Weiva Sieh Yurii B Shvetsov Alice S Whittemore Annette Staebler Beth Y Karlan Cristina Rodriguez-Antona David D Bowtell Ellen L Goode Estrid Høgdall Francisco J Candido Dos Reis Jacek Gronwald Jenny Chang-Claude Kirsten B Moysich Linda E Kelemen Linda S Cook Marc T Goodman Peter A Fasching Robin Crawford Suha Deen Usha Menon David G Huntsman Martin Köbel Susan J Ramus Paul D P Pharoah James D Brenton

Br J Cancer 2020 Sep 18;123(5):793-802. Epub 2020 Jun 18.

Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, England.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41416-020-0900-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463007PMC
September 2020

Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE).

Authors:
Aline Talhouk Joshy George Chen Wang Timothy Budden Tuan Zea Tan Derek S Chiu Stefan Kommoss Huei San Leong Stephanie Chen Maria P Intermaggio Blake Gilks Tayyebeh M Nazeran Mila Volchek Wafaa Elatre Rex C Bentley Janine Senz Amy Lum Veronica Chow Hanwei Sudderuddin Robertson Mackenzie Samuel C Y Leong Geyi Liu Dustin Johnson Billy Chen Aocs Group Jennifer Alsop Susana N Banerjee Sabine Behrens Clara Bodelon Alison H Brand Louise Brinton Michael E Carney Yoke-Eng Chiew Kara L Cushing-Haugen Cezary Cybulski Darren Ennis Sian Fereday Renée T Fortner Jesús García-Donas Aleksandra Gentry-Maharaj Rosalind Glasspool Teodora Goranova Casey S Greene Paul Haluska Holly R Harris Joy Hendley Brenda Y Hernandez Esther Herpel Mercedes Jimenez-Linan Chloe Karpinskyj Scott H Kaufmann Gary L Keeney Catherine J Kennedy Martin Köbel Jennifer M Koziak Melissa C Larson Jenny Lester Liz-Anne Lewsley Jolanta Lissowska Jan Lubiński Hugh Luk Geoff Macintyre Sven Mahner Iain A McNeish Janusz Menkiszak Nikilyn Nevins Ana Osorio Oleg Oszurek José Palacios Samantha Hinsley Celeste L Pearce Malcolm C Pike Anna M Piskorz Isabelle Ray-Coquard Valerie Rhenius Cristina Rodriguez-Antona Raghwa Sharma Mark E Sherman Dilrini De Silva Naveena Singh Peter Sinn Dennis Slamon Honglin Song Helen Steed Euan A Stronach Pamela J Thompson Aleksandra Tołoczko Britton Trabert Nadia Traficante Chiu-Chen Tseng Martin Widschwendter Lynne R Wilkens Stacey J Winham Boris Winterhoff Alicia Beeghly-Fadiel Javier Benitez Andrew Berchuck James D Brenton Robert Brown Jenny Chang-Claude Georgia Chenevix-Trench Anna deFazio Peter A Fasching María J García Simon A Gayther Marc T Goodman Jacek Gronwald Michelle J Henderson Beth Y Karlan Linda E Kelemen Usha Menon Sandra Orsulic Paul D P Pharoah Nicolas Wentzensen Anna H Wu Joellen M Schildkraut Mary Anne Rossing Gottfried E Konecny David G Huntsman Ruby Yun-Ju Huang Ellen L Goode Susan J Ramus Jennifer A Doherty David D Bowtell Michael S Anglesio

Clin Cancer Res 2020 Oct 17;26(20):5411-5423. Epub 2020 Jun 17.

British Columbia's Gynecological Cancer Research Program (OVCARE), BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-20-0103DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7572656PMC
October 2020

Sacrococcygeal teratoma in an adult containing a mucinous adenocarcinoma.

BMJ Case Rep 2020 Feb 11;13(2). Epub 2020 Feb 11.

Surgical Gynaecological Oncology, Barts Health NHS Trust, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bcr-2019-233308DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035798PMC
February 2020

The changing landscape of gynaecological pathology: WHO 2020 and beyond.

Histopathology 2020 01;76(1):2-5

Department of Pathology and Laboratory Medicine, Vancouver General Hospital, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.14035DOI Listing
January 2020

Vulval squamous cell carcinoma and its precursors.

Histopathology 2020 Jan;76(1):128-138

Vancouver General Hospital, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13989DOI Listing
January 2020

Metastases to the ovary arising from endometrial, cervical and fallopian tube cancer: recent advances.

Histopathology 2020 Jan;76(1):37-51

Department of Cellular Pathology, Barts Health NHS Trust, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13985DOI Listing
January 2020

p53 immunohistochemistry is an accurate surrogate for TP53 mutational analysis in endometrial carcinoma biopsies.

J Pathol 2020 03 29;250(3):336-345. Epub 2020 Jan 29.

Department of Pathology, University of Calgary, Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/path.5375DOI Listing
March 2020

Practical Guidance for Measuring and Reporting Surgical Margins in Vulvar Cancer.

Int J Gynecol Pathol 2020 Sep;39(5):420-427

Departments of Obstetrics and Gynecology (K.E.K., M.I.E.V.P.) Pathology (V.T.H.B.M.S., T.B.), Leiden University Medical Centre, Leiden, The Netherlands Department of Pathology, Ghent University Hospital, Gent (K.K.V.D.V.) Department of Pathology, University Hospitals Leuven, Leuven (A.S.V.R.), Belgium Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada (C.B.G.) Department of Cellular Pathology, Princess Alexandra Hospital, Harlow, Essex (S.A.) Department of Cellular Pathology, St. James's University Hospital, Leeds (D.A.) Department of Cellular Pathology, Barts Health NHS Trust, London (A.F., N.S.) Department of Cellular Pathology, University Hospitals Birmingham NHS Trust, Birmingham (R.G., B.T., J.V.) Department of Pathology, Airedale General Hospital, Keighley (N.R.G.) Department of Cellular Pathology, Stepping Hill Hospital, Stockport (R.H.) Department of Histopathology, Manor Hospital, Walsall Healthcare NHS Trust, Walsall (Y.L.H.) Department of Pathology, Belfast Health and Social Care Trust, Belfast (W.G.M.) Department of Cellular Pathology, Royal United Hospital, Bath (P.M.) Department of Pathology, Cambridge University Hospitals NHS Trust, Cambridge (B.R.) Department of Pathology, Royal Derby Hospital, Derby (G.V.S) Department of Histopathology, The Royal Sussex County Hospital, Brighton (M.V.), UK Division of Gynecologic, Breast & Perinatal Pathology, University Hospital Leipzig, Leipzig, Germany (L.C.H.) Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (K.J.P.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PGP.0000000000000631DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478209PMC
September 2020

Ovarian High-Grade Serous Carcinoma: Assessing Pathology for Site of Origin, Staging and Post-neoadjuvant Chemotherapy Changes.

Surg Pathol Clin 2019 Jun;12(2):515-528

Department of Cellular Pathology, Barts Health NHS Trust, The Royal London Hospital, 2nd Floor, 80 Newark Street, London E1 2ES, UK. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S18759181193000
Publisher Site
http://dx.doi.org/10.1016/j.path.2019.01.007DOI Listing
June 2019

Two versus four immunostains for Lynch syndrome screening in endometrial carcinoma.

Histopathology 2019 09 26;75(3):442-445. Epub 2019 Jul 26.

Department of Cellular Pathology, Barts Health NHS Trust, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13898DOI Listing
September 2019

Transtubal Spread of a Superficially Invasive Cervical Adenocarcinoma to the Ovaries After 11 Years.

Int J Gynecol Pathol 2020 May;39(3):296-300

Department of Pathology and Laboratory Medicine, Vancouver General Hospital and University of British Columbia, Vancouver, British Columbia, Canada (A.A., C.B.G.) Department of Cellular Pathology, Barts Health NHS Trust, London UK (N.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PGP.0000000000000603DOI Listing
May 2020

Synchronous carcinomas of endometrium and ovary: A pragmatic approach.

Gynecol Oncol Rep 2019 Feb 28;27:72-73. Epub 2018 Dec 28.

Dept of Cellular Pathology, BartsHealth NHS Trust, London, UK.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S23525789183012
Publisher Site
http://dx.doi.org/10.1016/j.gore.2018.12.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354202PMC
February 2019

Pathologic Prognostic Factors in Endometrial Carcinoma (Other Than Tumor Type and Grade).

Int J Gynecol Pathol 2019 Jan;38 Suppl 1:S93-S113

Department of Cellular Pathology, Barts Health NHS Trust, London (N.S.) Department of Cellular Pathology, Birmingham Women's NHS Trust, Birmingham (L.H.) Department of Pathology, Belfast Health and Social Care Trust, Belfast (W.G.M.), UK Division of Anatomic Pathology, Hershey Medical Center, Pennsylvania State University, Hershey, Pennsylvania (R.Z.) Department of Pathology, Mexico City Hospital of Oncology, Mexico City, Mexico (I.A.-C.) Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada (M.A.D.) Department of Pathology, Wayne State University, Detroit, Michigan (R.A.-F.) Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas (E.E., A.M.) Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School (J.L.H.) Department of Pathology, Brigham and Women's Hospital, Harvard Medical School (M.N.) Department of Pathology, Massachusetts General Hospital, Harvard Medical School (E.O.), Boston, Massachusetts Division of Gynecologic, Breast & Perinatal Pathology, University Hospital Leipzig, Leipzig (L.-C.H.) Institute of Pathology, University Hospital of Tübingen, Tübingen (A.S.), Germany Department of Anatomical Pathology, University of Maryland, College Park, Maryland (O.I.) Pathological Oncology Group and Pathology Department, University Hospital of Arnau de Vilanova, Lleida (X.M.-G.) Department of Pathology, Hospital Clinic of Barcelona, ISGlobal, Barcelona Center for International Health Research, University of Barcelona, Barcelona (J.O.), Spain Department of Diagnostic Pathology, Kumamoto University Hospital, Kumamoto, Japan (Y.M.) Department of Pathology, Yale University School of Medicine, New Haven, Connecticut (V.P.) Department of Pathology, Women and Infants Hospital/Warren Alpert Medical School of Brown University, Providence, Rhode Island (M.R.Q.) Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, Arkansas (C.M.Q.) Department of Pathology, University of California, San Francisco, San Francisco, California (C.Z.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PGP.0000000000000524DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6296841PMC
January 2019

Endometrial Carcinoma, Grossing and Processing Issues: Recommendations of the International Society of Gynecologic Pathologists.

Int J Gynecol Pathol 2019 Jan;38 Suppl 1:S9-S24

Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas (A.M., E.D.E.) Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School (J.L.H.) Department of Pathology, Massachusetts General Hospital and Harvard Medical School (E.O.), Boston, Massachusetts Department of Pathology, Wayne State University, Detroit, Michigan (R.A.F.) Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, Arkansas (C.M.Q.) Department of Cellular Pathology, Barts Health NHS Trust, London (N.S.) Department of Cellular Pathology, Birmingham Women's NHS Trust, Birmingham (L.H.), UK Division of Gynecologic, Breast and Perinatal Pathology, University Hospital, Leipzig (L.C.H.) Institute of Pathology, University Hospital of Tübingen, Tübingen (A.S.), Germany Department of Pathology, Hospital de Oncología Siglo XXI, Mexico City, Mexico City, Mexico (I.A.C.) Department of Pathology, Hospital Universitari de Bellvitge and Hospital Universitari de Arnau de Vilanova, Idibell, Irblleida, and Universitat de Lleida, Ciberonc (X.M.G.) Department of Pathology, Hospital Clinic of Barcelona, Universitat de Barcelona, Barcelona (J.O.), Spain Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Alberta, Canada (M.D.) Department of Pathology, Yale University School of Medicine, New Haven, Connecticut (V.P.) Department of Diagnostic Pathology, Kumamoto University Hospital, Kumamoto, Japan (Y.M.) Department of Pathology, Women and Infants Hospital and The Warren Alpert Medical School of Brown University, Providence, Rhode Island (M.R.Q.) Division of Anatomic Pathology, Hershey Medical Center, Pennsylvania State University, Hershey, Pennsylvania (R.Z.) Department of Pathology, University of California, San Francisco, San Francisco, California (C.Z.) Department of Pathology, Belfast Health and Social Care Trust, Belfast, UK (W.G.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PGP.0000000000000552DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6296844PMC
January 2019

Artefactual punctate MLH1 staining can lead to erroneous reporting of isolated PMS2 loss.

Histopathology 2018 10 12;73(4):703-705. Epub 2018 Jul 12.

Department of Cellular Pathology Barts Health NHS Trust, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13663DOI Listing
October 2018

Interpretation of P53 Immunohistochemistry in Endometrial Carcinomas: Toward Increased Reproducibility.

Int J Gynecol Pathol 2019 Jan;38 Suppl 1:S123-S131

Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta (M.K.) Department of Pathology, Vancouver General Hospital, Vancouver, British Columbia (C.B.G.), Canada Department of Pathology and Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, Baltimore, Maryland (B.M.R.) Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (R.A.S.) Department of Cellular Pathology, Barts Health NHS Trust, London (N.S.) Department of Pathology, Belfast Health and Social Care Trust, Belfast (W.G.M.), UK.

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00004347-900000000-9921
Publisher Site
http://dx.doi.org/10.1097/PGP.0000000000000488DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127005PMC
January 2019

Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer.

Authors:
Ellen L Goode Matthew S Block Kimberly R Kalli Robert A Vierkant Wenqian Chen Zachary C Fogarty Aleksandra Gentry-Maharaj Aleksandra Tołoczko Alexander Hein Aliecia L Bouligny Allan Jensen Ana Osorio Andreas Hartkopf Andy Ryan Anita Chudecka-Głaz Anthony M Magliocco Arndt Hartmann Audrey Y Jung Bo Gao Brenda Y Hernandez Brooke L Fridley Bryan M McCauley Catherine J Kennedy Chen Wang Chloe Karpinskyj Christiani B de Sousa Daniel G Tiezzi David L Wachter Esther Herpel Florin Andrei Taran Francesmary Modugno Gregg Nelson Jan Lubiński Janusz Menkiszak Jennifer Alsop Jenny Lester Jesús García-Donas Jill Nation Jillian Hung José Palacios Joseph H Rothstein Joseph L Kelley Jurandyr M de Andrade Luis Robles-Díaz Maria P Intermaggio Martin Widschwendter Matthias W Beckmann Matthias Ruebner Mercedes Jimenez-Linan Naveena Singh Oleg Oszurek Paul R Harnett Peter F Rambau Peter Sinn Philipp Wagner Prafull Ghatage Raghwa Sharma Robert P Edwards Roberta B Ness Sandra Orsulic Sara Y Brucker Sharon E Johnatty Teri A Longacre Eilber Ursula Valerie McGuire Weiva Sieh Yanina Natanzon Zheng Li Alice S Whittemore deFazio Anna Annette Staebler Beth Y Karlan Blake Gilks David D Bowtell Estrid Høgdall Francisco J Candido dos Reis Helen Steed Ian G Campbell Jacek Gronwald Javier Benítez Jennifer M Koziak Jenny Chang-Claude Kirsten B Moysich Linda E Kelemen Linda S Cook Marc T Goodman María José García Peter A Fasching Stefan Kommoss Suha Deen Susanne K Kjaer Usha Menon James D Brenton Paul DP Pharoah Georgia Chenevix-Trench David G Huntsman Stacey J Winham Martin Köbel Susan J Ramus

JAMA Oncol 2017 12;3(12):e173290

School of Women’s and Children’s Health, University of New South Wales, Sydney, Australia

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2017.3290DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5744673PMC
December 2017

Disease Distribution in Low-stage Tubo-ovarian High-grade Serous Carcinoma (HGSC): Implications for Assigning Primary Site and FIGO Stage.

Int J Gynecol Pathol 2018 Jul;37(4):324-330

Departments of Cellular Pathology (N.S., J.L.B., A.Z.F., G.T., S.L.S.L.) Gynaecological Oncology (C.G.), Barts Health NHS Trust Department of Pathology, University College Hospital NHS Trust (R.A.), London Department of Cellular Pathology, Birmingham Women's NHS Foundation Trust, Birmingham (L.H.) Department of Pathology, Belfast Health and Social Care Trust, Belfast, Northern Ireland (K.S., W.G.M.) St James's Hospital, Leeds (N.W.), UK British Columbia Cancer Agency (M.A., F.K.) Department of Pathology and Laboratory Medicine, University of British Columbia (C.B.G.), Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PGP.0000000000000429DOI Listing
July 2018

Persistence of fimbrial tissue on the ovarian surface after salpingectomy.

Am J Obstet Gynecol 2017 10 10;217(4):425.e1-425.e16. Epub 2017 Jun 10.

Department of Gynaecological Oncology, Royal London Hospital, Whitechapel, London, UK; Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajog.2017.06.004DOI Listing
October 2017

High-grade serous carcinoma of tubo-ovarian origin: recent developments.

Histopathology 2017 Sep 18;71(3):339-356. Epub 2017 Jul 18.

Department of Anatomic Pathology, Vancouver General Hospital, Vancouver, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13248DOI Listing
September 2017

Routine Appendicectomy is Unnecessary in Mucinous Borderline Ovarian Tumors.

Int J Gynecol Pathol 2018 Jan;37(1):57-58

Departments of Gynaecological Oncology (J.M., E.B., A.J.) Cellular Pathology (L.C., S.M., A.F., N.S.), Royal London Hospital, London Department of Obstetrics and Gynaecology, North Middlesex University Hospital (H.R.) East Kent Gynaecological Oncology Centre, QEQM Hospital, Margate (F.K.), UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PGP.0000000000000372DOI Listing
January 2018

HPV-independent Differentiated Vulvar Intraepithelial Neoplasia (dVIN) is Associated With an Aggressive Clinical Course.

Int J Gynecol Pathol 2017 Nov;36(6):507-516

Department of Gynecology and Obstetrics, Division of Gynecologic Oncology, University of British Columbia (J.N.M., S.Y.K., D.M.M.) Department of Pathology and Laboratory Medicine, University of British Columbia and BC Cancer Agency (A.A., S.E., C.B.G.) Vancouver, BC, Canada Department of Applied Tumor Biology, Institute of Pathology, University of Heidelberg, and Clinical Cooperation Unit Applied Tumor Biology, German Cancer Research Center (DKFZ), Heidelberg, Germany (M.R., M.v.K.D., E.S.P.) Department of Cellular Pathology, Barts and the London NHS Trust, London, UK (S.J., N.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PGP.0000000000000375DOI Listing
November 2017

Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening Study.

J Clin Oncol 2017 May 27;35(13):1411-1420. Epub 2017 Feb 27.

Adam N. Rosenthal, Lindsay S.M. Fraser, Susan Philpott, Ranjit Manchanda, Matthew Burnell, Philip Badman, Richard Hadwin, Ivana Rizzuto, Andy Ryan, Robert Liston, Jeremy Ford, Richard Gunu, Usha Menon, and Ian J. Jacobs, University College London Elizabeth Garrett Anderson Institute for Women's Health; Elizabeth Benjamin, University College London; Naveena Singh, Barts Health National Health Service Trust; Ranjit Manchanda, Barts Cancer Institute, Queen Mary University of London; Anne Dawnay, University College London Hospital; James Mackay, The University College London Cancer Institute, London; D. Gareth Evans, University of Manchester, St Mary's Hospital Manchester, Manchester; Diana M. Eccles, Southampton General Hospital, Southampton, United Kingdom; Steven J. Skates, Massachusetts General Hospital and Harvard Medical School, Boston, MA; and Ian J. Jacobs, University of New South Wales Australia, Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2016.69.9330
Publisher Site
http://dx.doi.org/10.1200/JCO.2016.69.9330DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455461PMC
May 2017

The changing landscape of gynaecological cancer diagnosis: implications for histopathological practice in the 21st century.

Histopathology 2017 Jan;70(1):56-69

Department of Anatomic Pathology, Vancouver General Hospital, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/his.13080
Publisher Site
http://dx.doi.org/10.1111/his.13080DOI Listing
January 2017

The Fallopian Tube Origin and Primary Site Assignment in Extrauterine High-grade Serous Carcinoma: Findings of a Survey of Pathologists and Clinicians.

Int J Gynecol Pathol 2017 May;36(3):230-239

Department of Pathology (W.G.M.), Belfast Health and Social Care Trust, BelfastDepartment of Cellular Pathology (L.H.), Birmingham Women's NHS Trust, BirminghamDepartment of Pathology (N.W.), St James's Hospital, LeedsDepartment of Cellular Pathology (N.S.), Barts Health NHS Trust, London, UKDepartment of Anatomic Pathology (C.B.G.), Vancouver General Hospital, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00004347-201705000-0000
Publisher Site
http://dx.doi.org/10.1097/PGP.0000000000000336DOI Listing
May 2017

Uterine Serous Carcinomas Frequently Metastasize to the Fallopian Tube and Can Mimic Serous Tubal Intraepithelial Carcinoma.

Am J Surg Pathol 2017 Feb;41(2):161-170

*Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada †Department of Cellular Pathology, Barts NHS Trust ‡Department of Cellular Pathology, Barts and the London NHS Trust, London §St James's Hospital, Leeds ∥Department of Pathology, Belfast Health and Social Care Trust, Belfast, Northern Ireland, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000757DOI Listing
February 2017

Assessment of CK17 as a Marker for the Diagnosis of Differentiated Vulvar Intraepithelial Neoplasia.

Int J Gynecol Pathol 2017 May;36(3):273-280

Department of Pathology and Laboratory Medicine, University of Louisville, Louisville, Kentucky (M.B.P., M.A.S.)Department of Pathology, Floyd Memorial Hospital, New Albany, Indiana (M.M.)Department of Cellular Pathology, Barts and the London NHS Trust, London, United Kingdom (N.S.)Department of Pathology and Laboratory Medicine, Vancouver General Hospital and University of British Columbia, Vancouver, Canada (C.B.G.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PGP.0000000000000317DOI Listing
May 2017

The Chemotherapy Response Score (CRS): Interobserver Reproducibility in a Simple and Prognostically Relevant System for Reporting the Histologic Response to Neoadjuvant Chemotherapy in Tuboovarian High-grade Serous Carcinoma.

Int J Gynecol Pathol 2017 Mar;36(2):172-179

Department of Cellular Pathology (I.S., A.Z.F., S.J., S.L.S.L., J.M., T.O.M., N.S.) Department of Medical Oncology (S.B.), Barts Health NHS Trust Department of Pathology (P.E., G.T.), University College Hospital NHS Trust, London Department of Cellular Pathology (J.B., R.G., L.H., R.M., J.V.), Birmingham Women's NHS Trust, Birmingham Department of Pathology (W.G.M.), Belfast Health and Social Care Trust, Royal Victoria Hospital, Belfast, UK Department of Anatomic Pathology (C.B.G.), Vancouver General Hospital, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PGP.0000000000000307DOI Listing
March 2017

A Case of Stage 4B Seromucinous Ovarian Borderline Tumor With Endometriosis and Review of the Literature.

Int J Gynecol Pathol 2017 Mar;36(2):195-199

Royal London Hospital, Whitechapel Road, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PGP.0000000000000304DOI Listing
March 2017

Adopting a Uniform Approach to Site Assignment in Tubo-Ovarian High-Grade Serous Carcinoma: The Time has Come.

Int J Gynecol Pathol 2016 May;35(3):230-7

Department of Cellular Pathology (N.S.), Barts Health NHS Trust, LondonDepartment of Cellular Pathology (L.H.), Birmingham Women's NHS Trust, BirminghamDepartment of Pathology (N.W.), St James's Hospital, LeedsDepartment of Pathology (W.G.M), Belfast Health and Social Care Trust, Belfast, UKDepartment of Anatomic Pathology (C.B.G.), Vancouver General Hospital, and University of British Columbia, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PGP.0000000000000270DOI Listing
May 2016

Primary site assignment in tubo-ovarian high-grade serous carcinoma: Consensus statement on unifying practice worldwide.

Gynecol Oncol 2016 05 28;141(2):195-198. Epub 2016 Jan 28.

Department of Pathology, Belfast Health and Social Care Trust, Royal Victoria Hospital, Grosvenor Road, Belfast BT12 6BA, UK. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00908258153016
Publisher Site
http://dx.doi.org/10.1016/j.ygyno.2015.10.022DOI Listing
May 2016

p16 Immunostaining Allows for Accurate Subclassification of Vulvar Squamous Cell Carcinoma Into HPV-Associated and HPV-Independent Cases.

Int J Gynecol Pathol 2016 Jul;35(4):385-93

Department of Cellular Pathology (S.J., N.S.), Barts Health NHS Trust, London, United Kingdom Department of Pathology and Laboratory Medicine (A.S.C., A.N.K., C.B.G.), Vancouver General Hospital Department of Obstetrics and Gynecology (J.N.M.), Division of Gynecologic Oncology, University of British Columbia, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PGP.0000000000000263DOI Listing
July 2016

The secondary Müllerian system, field effect, BRCA, and tubal fimbria: our evolving understanding of the origin of tubo-ovarian high-grade serous carcinoma and why assignment of primary site matters.

Pathology 2015 Aug;47(5):423-31

1Departments of Pathology, Barts Health NHS Trust, London, United Kingdom 2Vancouver General Hospital and University of British Columbia, Vancouver, Canada 3St James' Hospital, Leeds 4Royals Hospitals Trust, Belfast, United Kingdom.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00313025163007
Publisher Site
http://dx.doi.org/10.1097/PAT.0000000000000291DOI Listing
August 2015

Chemotherapy Response Score: Development and Validation of a System to Quantify Histopathologic Response to Neoadjuvant Chemotherapy in Tubo-Ovarian High-Grade Serous Carcinoma.

J Clin Oncol 2015 Aug 29;33(22):2457-63. Epub 2015 Jun 29.

Steffen Böhm, Asma Faruqi, Ian Said, Michelle Lockley, Elly Brockbank, Arjun Jeyarajah, Amanda Fitzpatrick, and Naveena Singh, Barts Health National Health Service Trust; Steffen Böhm, Michelle Lockley, Darren Ennis, and Thomas Dowe, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom; Jennifer L. Santos, Anna V. Tinker, and Nhu D. Le, British Columbia Cancer Agency; C. Blake Gilks, University of British Columbia, Vancouver, BC, Canada; and Linda S. Cook, University of New Mexico, Albuquerque, NM.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2015/06/24/JCO.2014.60
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2014.60.5212
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.60.5212DOI Listing
August 2015

Diagnosis of Ovarian Carcinoma Histotype Based on Limited Sampling: A Prospective Study Comparing Cytology, Frozen Section, and Core Biopsies to Full Pathologic Examination.

Int J Gynecol Pathol 2015 Nov;34(6):517-27

Department of Pathology and Laboratory Medicine, Vancouver General Hospital and University of British Columbia, Vancouver, Canada (L.N.H., S.Z., D.H., C.B.G.) Department of Histopathology, King Edward Memorial Hospital, Perth, Western Australia, Australia (A.S.) Department of Pathology and Laboratory Medicine, Calgary Laboratory Services and University of Calgary, Calgary, Canada (M.K.) Department of Laboratory Medicine and Pathology, Royal Alexandra Hospital and University of Alberta, Edmonton, Canada (C.H.L.) Department of Gynecology and Obstetrics, University of British Columbia, Vancouver, BC, Canada (J.N.M., D.H.) Department of Pathology, British Columbia Cancer Agency, Vancouver, BC, Canada (D.H., T.T., D.V.N.) Department of Cellular Pathology, Barts and the London NHS Trust, London, United Kingdom (N.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PGP.0000000000000199DOI Listing
November 2015

Morphologic and Molecular Characteristics of Mixed Epithelial Ovarian Cancers.

Am J Surg Pathol 2015 Nov;39(11):1548-57

*Department of Molecular Oncology §Cancer Control Research, BC Cancer Agency Cancer Research Centre †Department of Pathology and Laboratory Medicine ‡Genetic Pathology Evaluation Centre, Anatomical Pathology at the Vancouver General Hospital ‡‡Department of Gynecology and Obstetrics, Division of Gynecologic Oncology, University of British Columbia, Vancouver, BC, Canada ∥Department of Internal Medicine, University of New Mexico, Albuquerque, NM §§Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, AB ¶The Leeds Teaching Hospitals NHS Trust, Leeds #Barts Health NHS Trust, London, United Kingdom **Institut für Pathologie, Referenzzentrum für Gynäkopathologie, Mannheim ††Gynecologic Oncology Center, Kiel ∥∥Department of Gynecology and Obstetrics, Tuebingen University Women's Hospital, Tuebingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000476DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604016PMC
November 2015

Risk Algorithm Using Serial Biomarker Measurements Doubles the Number of Screen-Detected Cancers Compared With a Single-Threshold Rule in the United Kingdom Collaborative Trial of Ovarian Cancer Screening.

J Clin Oncol 2015 Jun 11;33(18):2062-71. Epub 2015 May 11.

Usha Menon, Andy Ryan, Jatinderpal Kalsi, Aleksandra Gentry-Maharaj, Mariam Habib, Sophia Apostolidou, Matthew Burnell, Susan Davies, Richard Gunu, Martin Widschwendter, Elizabeth Benjamin, Mahesh Parmar, and Ian Jacobs, University College London; Anne Dawnay and Tim Mould, University College London Hospital; Naveena Singh, Barts and the London School of Medicine and Dentistry; David Oram and Karina Reynolds, St Bartholomew's Hospital; Alistair McGuire, London School of Economics; Stuart Campbell, Create Health Clinic; Aarti Sharma, University Hospital of Wales; Nazar N. Amso, Cardiff University, Cardiff; Keith Godfrey, Queen Elizabeth Hospital, Gateshead; Alberto Lopes, Royal Cornwall Hospital, Truro; Jonathan Herod, Liverpool Women's Hospital, Liverpool; Karin Williamson, Nottingham City Hospital, Nottingham; Mourad W. Seif, St Mary's Hospital, Manchester; Howard Jenkins and Ian Scott, Royal Derby Hospital, Derby; Robert Woolas, Queen Alexandra Hospital, Portsmouth; John B. Murdoch, St Michael's Hospital, Bristol; Stephen Dobbs, Belfast City Hospital, Belfast; Simon Leeson, Llandudno Hospital, Ysbyty Gwynedd; Derek Cruickshank, James Cook University Hospital, Middlesbrough; Lesley Fallowfield, University of Sussex, Falmer, United Kingdom; Steven J. Skates, Massachusetts General Hospital and Harvard Medical School, Boston, MA; and Ian Jacobs, UNSW Australia, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2014.59.4945
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.59.4945DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4463475PMC
June 2015

Tubal handling significantly affects site assignment in non-uterine high-grade serous carcinoma.

Histopathology 2015 Oct 29;67(4):585-7. Epub 2015 Apr 29.

Department of Cellular Pathology, Barts Health NHS Trust, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.12687DOI Listing
October 2015

Assessment of a new system for primary site assignment in high-grade serous carcinoma of the fallopian tube, ovary, and peritoneum.

Histopathology 2015 Sep 31;67(3):331-7. Epub 2015 Mar 31.

Department of Pathology, Belfast Health and Social Care Trust, Belfast, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.12651DOI Listing
September 2015

Incidental nonuterine high-grade serous carcinomas arise in the fallopian tube in most cases: further evidence for the tubal origin of high-grade serous carcinomas.

Am J Surg Pathol 2015 Mar;39(3):357-64

*Department of Pathology, Vancouver General Hospital and University of British Columbia, Vancouver †Department of Pathology, Royal Jubilee Hospital, Victoria, BC ‡Department of Pathology, Calgary Laboratory Services and University of Calgary, AB §Department of Pathology, Royal Alexandra Hospital and University of Alberta, Edmonton AB ∥Department of Cellular Pathology, Barts Health NHS Trust, London ¶Department of Histopathology, St James's Hospital, Leeds #Department of Pathology, Belfast Health and Social Care Trust, Belfast, United Kingdom.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/ajsp/2015/03000/Incidental_Nonu
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/PAS.0000000000000353DOI Listing
March 2015

Risk of preterm delivery with increasing depth of excision for cervical intraepithelial neoplasia in England: nested case-control study.

BMJ 2014 Nov 5;349:g6223. Epub 2014 Nov 5.

Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Bart's and the London School of Medicine, Queen Mary University of London, London EC1M 6BQ, UK

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220819PMC
http://dx.doi.org/10.1136/bmj.g6223DOI Listing
November 2014

The histomorphology of Lynch syndrome-associated ovarian carcinomas: toward a subtype-specific screening strategy.

Am J Surg Pathol 2014 Sep;38(9):1173-81

Departments of *Laboratory Medicine and Pathobiology ‡Obstetrics and Gynecology, Faculty of Medicine, University of Toronto §Division of Gynecologic Oncology §§Department of Pathology, University Health Network ∥Department of Laboratory Medicine and Pathology ¶Zane Cohen Centre for Digestive Diseases, Familial Gastrointestinal Cancer Registry ‡‡Division of General Surgery, Mount Sinai Hospital, Toronto, ON ∥∥Department of Medical Genetics, McGill University Health Centre, Montreal, QB #Division of Gynecologic Oncology ¶¶Department of Pathology and Laboratory Medicine, Faculty of Medicine, University of British Columbia and BC Cancer Agency, Vancouver, BC, Canada †Department of Pathology, Bon Secours Hospital, Cork, Ireland **Department of Histopathology, King Edward Memorial Hospital for Women, Perth, Australia ††Department of Cellular Pathology, Barts Health NHS Trust, London, United Kingdom.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/ajsp/2014/09000/The_Histomorpho
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/PAS.0000000000000298DOI Listing
September 2014

Expanding the morphologic spectrum of differentiated VIN (dVIN) through detailed mapping of cases with p53 loss.

Am J Surg Pathol 2015 Jan;39(1):52-60

Departments of *Cellular Pathology ‡Gynecological Oncology, Barts Health NHS Trust, London, United Kingdom †Department of Pathology, Sunnybrook Health Sciences Centre, Toronto, ON §Department of Pathology ∥Division of Gynecological Oncology, Vancouver General Hospital, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000291DOI Listing
January 2015

Assignment of primary site in high-grade serous tubal, ovarian and peritoneal carcinoma: a proposal.

Histopathology 2014 Aug 20;65(2):149-54. Epub 2014 May 20.

Department of Cellular Pathology, Barts Health NHS Trust, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.12419DOI Listing
August 2014

Ovarian cellular fibromas lack FOXL2 mutations: a useful diagnostic adjunct in the distinction from diffuse adult granulosa cell tumor.

Am J Surg Pathol 2013 Sep;37(9):1450-5

*Department of Pathology, Belfast Health and Social Care Trust, Belfast †Department of Pathology, Barts Health NHS Trust, London, United Kingdom ‡Centre for Translational and Applied Genomics §Department of Pathology, University of British Columbia ∥Department of Pathology, Vancouver General Hospital, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0b013e31828e4f55DOI Listing
September 2013

The MRI features of histologically proven ovarian cystadenofibromas-an assessment of the morphological and enhancement patterns.

Eur Radiol 2013 Jan 20;23(1):48-56. Epub 2012 Jul 20.

Imaging Department, Barts and the London NHS Trust, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00330-012-2568-1DOI Listing
January 2013

Pathology of primary and metastatic mucinous ovarian neoplasms.

J Clin Pathol 2012 Jul 10;65(7):591-5. Epub 2011 Nov 10.

Department of Cellular Pathology, Barts and the London NHS Trust, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jclinpath-2011-200162DOI Listing
July 2012

Is differentiated vulval intraepithelial neoplasia the precursor lesion of human papillomavirus-negative vulval squamous cell carcinoma?

Int J Gynecol Cancer 2011 Oct;21(7):1297-305

Department of Gynaecological Oncology, Barts and the London NHS Trust, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0b013e31822dbe26DOI Listing
October 2011

Perforation of a malignant ovarian tumor into the recto-sigmoid colon.

Acta Obstet Gynecol Scand 2010 Oct;89(10):1362-3

Department of Gynaecological Oncology, St Bartholomew's Hospital, West Smithfield, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/00016349.2010.501857DOI Listing
October 2010

Synchronous tumours of the female genital tract.

Authors:
Naveena Singh

Histopathology 2010 Feb;56(3):277-85

Department of Cellular Pathology, Barts and the London NHS Trust, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2559.2009.03367.xDOI Listing
February 2010

Performance of anal cytology in a clinical setting when measured against histology and high-resolution anoscopy findings.

AIDS 2010 Jan;24(3):373-9

Department of Sexual Health, Homerton University Hospital NHS Foundation Trust, London E9 6SR, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0b013e328333ab8eDOI Listing
January 2010

Clinical value of immunohistochemically detected lymphatic and vascular invasions in clinically staged endometrioid endometrial cancer.

Int J Gynecol Cancer 2009 Aug;19(6):1074-9

Department of Gynaecological Oncology, Glasgow Royal Infirmary, Castle Street, Glasgow, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/IGC.0b013e3181abb0c0DOI Listing
August 2009

The clonal evolution of metastases from primary serous epithelial ovarian cancers.

Int J Cancer 2009 Apr;124(7):1579-86

Gynaecological Cancer Research Laboratories, UCL EGA Institute for Women's Health, University College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.24148DOI Listing
April 2009

Predicting clinical outcome in patients diagnosed with synchronous ovarian and endometrial cancer.

Clin Cancer Res 2008 Sep;14(18):5840-8

Gynaecological Cancer Research Laboratory, University College London Elizabeth Garrett Anderson Institute for Women's Health, University College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-08-0373DOI Listing
September 2008

Clinical value of immunohistochemically detected lymphovascular space invasion in early stage cervical carcinoma.

Ann Surg Oncol 2008 Sep 12;15(9):2581-8. Epub 2008 Jul 12.

Cancer Research-United Kingdom Translational Oncology Laboratory, St. Bartholomew's and the Royal London School of Medicine and Dentistry, John Vane Building, Charterhouse Square, London, EC1M 6BQ, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-008-0014-zDOI Listing
September 2008

Solitary fibrous tumor of the female genital tract a case report and review of the literature.

Int J Gynecol Pathol 2007 Jul;26(3):259-64

Institute of Pathology, Royal London Hospital, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.pgp.0000250144.59839.a8DOI Listing
July 2007

Molecular assessment of depth of myometrial invasion in stage I endometrial cancer: a model based on K-ras mutation analysis.

Gynecol Oncol 2003 Oct;91(1):218-25

ICRF Translational Oncology Laboratory, St. Bartholomew's and the Royal London Medical and Dental School, Charterhouse Square, London, EC1M 6BQ, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0090-8258(03)00505-5DOI Listing
October 2003

Telepathology in a routine clinical environment: implementation and accuracy of diagnosis by robotic microscopy in a one-stop breast clinic.

J Pathol 2002 Mar;196(3):351-5

Department of Histopathology, Barts and the London NHS Trust, St Bartholomew's Hospital, West Smithfield, London EC1A 7BE, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/path.1049DOI Listing
March 2002